logo
  

Alibaba Upsizes Share Repurchase To $25 Bln From $15 Bln; Stock Up

Shares of Alibaba Group Holding Ltd. (BABA) were gaining around 10 percent in Hong Kong trading after the Chinese online retail giant announced Tuesday that its board has authorized to upsize its share repurchase program to $25 billion from $15 billion. According to the company, the move is a sign of confidence about its continued growth in the future.

The company also announced that Weijian Shan, executive chairman of investment group PAG, was appointed as an independent director to its board, effective March 31. He will serve on the board's audit committee. Börje Ekholm, Ericsson President and Chief Executive Officer, will retire from the board on March 31. Ekholm has served as an independent director since June 2015.

Alibaba said its Share Repurchase Program will be effective for a two-year period through March 2024. As of March 18, the company had purchased a total of 56.2 million American depositary shares under the previously announced share repurchase program, for a total consideration of approximately $9.2 billion.

Alibaba served about 1 billion consumers in China and 300 million around the world in 2021.

In Hong Kong, Alibaba Group shares were trading at HK$109.10, up 10.09 percent.

On the NYSE, Alibaba closed Monday's trading down 4.4 percent at $103.59.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT